|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hepatitis C virus: Virology, diagnosis and management ofantiviral therapy显示文摘Hepatitis C virus (HCV) infects approximately 170 million individuals worldwide. Prevention of HCV infection complications is based on antiviral therapy with the combination of pegylated interferon alfa and ribavirin. The use of serological and virological tests has become essential in the management of HCV infection in order to diagnose infection, guide treatment decisions and assess the virological response to antiviral therapy. Anti- HCV antibody testing and HCV RNA testing are used to diagnose acute and chronic hepatitis C. The HCV genotype should be systematically determined before treatment, as it determines the indication, the duration of treatment, the dose of ribavirin and the virological monitoring procedure. HCV RNA monitoring during therapy is used to tailor treatment duration in HCV genotype 1 infection, and molecular assays are used to assess the end-of-treatment and, most importantly the sustained virological response, i.e. the endpoint of therapy. | Stéphane Chevaliez Jean-Michel Pawlotsky | 2007 | World Journal of Gastroenterology2007，13，17： | 17 |
| 2 | New Virologic Tools for Management of Chronic Hepatitis B and C显示文摘 | Stéphane Chevaliez Christophe Rodriguez Jean–Michel Pawlotsky | 2012 | Gastroenterology2012，，6： | 4 |
| 3 | Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely显示文摘 | Stéphane Chevaliez Christophe Hézode Stéphane Bahrami Marion Grare Jean-Michel Pawlotsky | 2012 | Journal of Hepatology2012，，： | 2 |
| 4 | High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial)显示文摘 | Chevaliez S Hezode C Soulier A et d | 2011 | Gastroenterology2011，141，1： | 1 |
| 5 | Virological tools to diagnose and monitor hepatitis C infection显示文摘 | Chevaliez S | 2011 | Clin Microb Inf2011，17，2： | 1 |
| 6 | Characterization of V36c ,a novel amino acid substitution conferring hepatitis C virus (HCV) resistance to telaprevir, a potent pepti -domimetic inhibitor of HCV protease显示文摘 | Barbotte L Ahmed - Belkacem A Chevaliez S | 2010 | Antimicrob Agents Chemother2010，54，6： | 1 |
| 7 | Improvement of hepatitis C virus (HCV) genotype determination with the new version of the 1NNO-LiPA HCV assay 显示文摘 | Bouchardeau F Cantaloube J F Chevaliez S | 2007 | J Clin Microbiol2007，45，4： | 1 |
| 8 | Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily显示文摘 | Hezode C Chevaliez S Bouvier-Alias M | 2007 | J Heoatol2007，46，5： | 1 |
| 9 | Diagnosis and management of chronic viral hepatitis: Antigens, antibodies and viral genomes显示文摘 | Stéphane Chevaliez Jean-Michel Pawlotsky | 2008 | Best Practice & Research Clinical Gastroenterology2008，，6： | 1 |
| 10 | The Cobas AmpliPrep-Cobas TaqMan real-time polymerase chain reaction assay fails to detect hepatitis C virus RNA in highly viremic genotype 4 clinical samples显示文摘 | Chevaliez S Bouvier-Alias M Cast e ra L | 2009 | Hepatology2009，49，4： | 1 |
| 11 | Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method显示文摘 | Chevaliez S Bouvier-Alias M Brillet R | 2007 | Hepatology2007，46，1： | 1 |
| 12 | The Hepatitis C Virus Life Cycle as a Target for New Antiviral Therapies显示文摘 | Jean–Michel Pawlotsky Stéphane Chevaliez John G. McHutchison | 2007 | Gastroenterology2007，，5： | 1 |
| 13 | Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis C显示文摘 | Stéphane Chevaliez Alexandre Soulier Lila Poiteau Magali Bouvier-Alias Jean-Michel Pawlotsky | 2014 | Journal of Clinical Virology2014，，： | 1 |
| 14 | Molecular comparison of echovirus 11 strains circulating in Europe during an epidemic of multisystem hemorrhagic disease of infants indicates that evolution generally occurs by recombination显示文摘 | Chevaliez S Szendroi A Caro V | 2004 | J Virol2004，325，： | 1 |
| 15 | Hepatitis C Virus(HCV)genotype 1 subtype identification in new HCV drug development and future clinical practice显示文摘 | Chevaliez S Bouvier-Alias M Brillet R | 2009 | PLoS ONE2009，4，12： | 1 |
| 16 | Molecular comparison of echovirus 11strains circulating in Europe during an epidemic of multisystem hemorrhagic disease of infants indicates that evolution generally occurs by recombination显示文摘 | Chevaliez S Szendroi A Caro V Balanant J Guillot S Berencsi G Delpeyroux F | 2004 | Virology2004，325，1： | 1 |
| 17 | 1142 RIBAVIRIN IS A TLR7 AGONIST AND ITS ANTIVIRAL EFFECT ON HCV IS AT LEAST PARTLY RELATED TO THE INDUCTION OF IRF7 EXPRESSION显示文摘 | S. Chevaliez P. Bensadoun A. Belle J.-M. Pawlotsky | 2013 | Journal of Hepatology2013，，： | 1 |
| 18 | Virological tools to diagnose and monitor hep- atitis C virus infection显示文摘 | Chevaliez S | 2011 | Clin Microbiol Infect2011，17，2： | 1 |
| 19 | High-Dose Pegylated Interferon-alpha and Ribavirin in Nonresponder Hepatitis C Patients and Relationship With IL-288 Genotype(SYREN Trial)显示文摘 | Chevaliez S Hezode C Soulier A | | Gastroenterology0，，： | 1 |
| 20 | Hepatitis C virus serologicaland virological tests and clinical diagnosis of HCV realat-ed liver disease 显示文摘 | Chevaliez S Pawlostsky JM | 2006 | Med Sci USA2006，3，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员